Skip Navigation


Rheumatology Advance Access originally published online on December 16, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/4/423    most recent
keh063v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saruhan-Direskeneli, G.
Right arrow Articles by Gül, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saruhan-Direskeneli, G.
Right arrow Articles by Gül, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2004; 43: 423-427
Rheumatology Vol. 43 No. 4 (c) British Society for Rheumatology 2004; all rights reserved


Basic Science

Expression of KIR and C-type lectin receptors in Behçet's disease

G. Saruhan-Direskeneli1, F. A. Uyar1, A. Çefle2, S. Ç. Onder2, E. Eksioglu-Demiralp3, S. Kamali, M. Inanç2, L. Ocal2 and A. Gül2

1Department of Physiology and 2Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University and 3Department of Immunology, Marmara University Medical Faculty, Istanbul, Turkey.

Correspondence to: G. Saruhan-Direskeneli, Department of Physiology, Istanbul Faculty of Medicine, 34093 Çapa, Istanbul, Turkey. E-mail: gsaruhan{at}istanbul.edu.tr

Objective. Behçet's disease (BD) is a multisystemic disorder with a possible underlying pathology of immune-mediated vasculitis. Genetic susceptibility associated with HLA-B*51 and B*2702 has been implicated in its pathogenesis. Considering the recently defined regulatory mechanisms of NK cells through HLA class I binding receptors, we hypothesized that interactions of NK and T cells through the NK receptors may be important in the pathogenesis of BD.

Methods. The impact of different expression patterns of HLA-recognizing receptors on NK or T cells was analysed in 51 patients with BD and 32 healthy controls. We used flow cytometry to investigate the expression of KIR3DL1 from the polymorphic killer immunoglobulin-like receptor (KIR) family, which binds a shared HLA-Bw4 motif on HLA-B51 and *2702 alleles, and CD94 from the conserved C-type lectin receptor family, which binds HLA-E. Thirty-three of the BD patients and 19 of the controls carried the same HLA-Bw4 motif.

Results. CD3+ T cells were increased in patients with BD compared with controls (81 vs 75%, P = 0.001), whereas the NK cells did not show any difference between the two groups. Increased expression of CD94 in BD was observed on CD16+CD56+ cells (66 vs 57, P = 0.04) and on CD3+ (7.7 vs 4.0, P < 0.001) and CD3+CD56+ (44 vs 35, P = 0.02) T cells. KIR3DL1 expression on the NK and T cells was not statistically different between the two groups. No effect of HLA-Bw4 motif was observed on the expression of CD94 and KIR3DL1 in both the patients and the controls.

Conclusion. The absence of a correlation between KIR3DL1 expression and HLA-Bw4 motif confirms previous work reporting that the expression of these molecules is regulated separately. Increased expression of CD94 may suggest that NK receptors play a pathogenic or regulatory role in BD.

KEY WORDS: Behçet's disease, NK cell, KIR3DL1, CD94, HLA-B51, HLA-Bw4.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.